Actively Recruiting
Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
Led by Leiden University Medical Center · Updated on 2026-02-13
400
Participants Needed
11
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This real-world, international registry aims to evaluate the current experience with sodium-glucose cotransporter 2 inhibitors (SGLT2i) in adult congenital heart disease (ACHD) patients by investigating the prescription patterns, safety, tolerability, and potential beneficial effects on heart failure-related outcomes.
CONDITIONS
Official Title
Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Congenital heart defect
- Age 18 years or older
- Started treatment with an SGLT2 inhibitor
You will not qualify if you...
- No consent for data collection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 11 locations
1
Johns Hopkins University
Baltimore, Maryland, United States, 21205
Actively Recruiting
2
Helen DeVos Children's Hospital
Grand Rapids, Michigan, United States, 49503
Actively Recruiting
3
Mount Sinai Fuster Heart Hospital
New York, New York, United States, 10029
Actively Recruiting
4
Heart Center Duisburg (Evangelical Hospital Niederrhein)
Duisburg, Germany
Actively Recruiting
5
Leiden University Medical Center (LUMC)
Leiden, South Holland, Netherlands, 2333ZA
Actively Recruiting
6
Amsterdam University Medical Center
Amsterdam, Netherlands
Actively Recruiting
7
University Medical Center Utrecht
Utrecht, Netherlands
Actively Recruiting
8
Zan Mitrev Clinic
Skopje, North Macedonia
Actively Recruiting
9
University Hospital of Wales
Cardiff, United Kingdom
Actively Recruiting
10
Golden Jubilee University National Hospital
Glasgow, United Kingdom
Actively Recruiting
11
Barts Heart Centre
London, United Kingdom
Actively Recruiting
Research Team
R
Ralph M.L. Neijenhuis, MD
CONTACT
B
Björn N. Westdorp, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here